Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review

<h3>Background</h3><p dir="ltr">The SARS-CoV-2 virus elicited a major public concern worldwide since December 2019 due to the high number of infections and deaths caused by COVID-19. The Omicron variant was detected in October 2021 which evolved from the wild-type SARS-Co...

Full description

Saved in:
Bibliographic Details
Main Author: Maryam Arabi (3927509) (author)
Other Authors: Yousef Al-Najjar (14147835) (author), Omna Sharma (16449442) (author), Ibtihal Kamal (16449445) (author), Aimen Javed (16449448) (author), Harsh S. Gohil (16449451) (author), Pradipta Paul (12628162) (author), Aljazi M. Al-Khalifa (16449454) (author), Sa’ad Laws (9620660) (author), Dalia Zakaria (14779459) (author)
Published: 2023
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513526901506048
author Maryam Arabi (3927509)
author2 Yousef Al-Najjar (14147835)
Omna Sharma (16449442)
Ibtihal Kamal (16449445)
Aimen Javed (16449448)
Harsh S. Gohil (16449451)
Pradipta Paul (12628162)
Aljazi M. Al-Khalifa (16449454)
Sa’ad Laws (9620660)
Dalia Zakaria (14779459)
author2_role author
author
author
author
author
author
author
author
author
author_facet Maryam Arabi (3927509)
Yousef Al-Najjar (14147835)
Omna Sharma (16449442)
Ibtihal Kamal (16449445)
Aimen Javed (16449448)
Harsh S. Gohil (16449451)
Pradipta Paul (12628162)
Aljazi M. Al-Khalifa (16449454)
Sa’ad Laws (9620660)
Dalia Zakaria (14779459)
author_role author
dc.creator.none.fl_str_mv Maryam Arabi (3927509)
Yousef Al-Najjar (14147835)
Omna Sharma (16449442)
Ibtihal Kamal (16449445)
Aimen Javed (16449448)
Harsh S. Gohil (16449451)
Pradipta Paul (12628162)
Aljazi M. Al-Khalifa (16449454)
Sa’ad Laws (9620660)
Dalia Zakaria (14779459)
dc.date.none.fl_str_mv 2023-06-26T03:00:00Z
dc.identifier.none.fl_str_mv 10.1186/s12879-023-08328-3
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Role_of_previous_infection_with_SARS-CoV-2_in_protecting_against_omicron_reinfections_and_severe_complications_of_COVID-19_compared_to_pre-omicron_variants_a_systematic_review/25256638
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Clinical sciences
Omicron
Delta
Alpha
SARS-CoV-2
COVID-19
Efectiveness
Vaccine
Previous infection
Reinfection
dc.title.none.fl_str_mv Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <h3>Background</h3><p dir="ltr">The SARS-CoV-2 virus elicited a major public concern worldwide since December 2019 due to the high number of infections and deaths caused by COVID-19. The Omicron variant was detected in October 2021 which evolved from the wild-type SARS-CoV-2 and was found to possess many mutations. Omicron exhibited high transmissibility and immune evasion as well as reduced severity when compared to the earlier variants. Although vaccinated individuals were largely protected against infections in previous waves, the high prevalence of both reinfections and breakthrough infections with Omicron was observed. The aim of this review is to understand the effectiveness of previous infection on subsequent reinfection, given its significance in driving public health policy, including vaccination prioritization and lockdown requirements.</p><h3>Methods</h3><p dir="ltr">A comprehensive literature search was conducted using several databases to target studies reporting data related to the effectiveness of the previous infection with SARS-CoV-2 in protecting against the Omicron variant. Screening of the studies, quality assessment and data extraction were conducted by two reviewers for each study.</p><h3>Results</h3><p dir="ltr">Only 27 studies met our inclusion criteria. It was observed that previous infection was less effective in preventing reinfections with the Omicron variant compared to the Delta variant irrespective of vaccination status. Furthermore, being fully vaccinated with a booster dose provided additional protection from the Omicron variant. Additionally, most infections caused by Omicron were asymptomatic or mild and rarely resulted in hospitalizations or death in comparison to the Delta wave.</p><h3>Conclusion</h3><p dir="ltr">A majority of the studies reached a consensus that although previous infection provides some degree of immunity against Omicron reinfection, it is much lower in comparison to Delta. Full vaccination with two doses was more protective against Delta than Omicron. Receiving a booster dose provided additional protection against Omicron. It is therefore clear that neither vaccination nor previous infection alone provide optimal protection; hybrid immunity has shown the best results in terms of protecting against either Omicron or Delta variants. However, additional research is needed to quantify how long immunity from vaccination versus previous infection lasts and whether individuals will benefit from variant-specific vaccinations to enhance protection from infection.</p><h2>Other Information</h2><p dir="ltr">Published in: BMC Infectious Diseases<br>License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1186/s12879-023-08328-3" target="_blank">https://dx.doi.org/10.1186/s12879-023-08328-3</a></p>
eu_rights_str_mv openAccess
id Manara2_0399fc98175569106fc0c2c05f4098de
identifier_str_mv 10.1186/s12879-023-08328-3
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/25256638
publishDate 2023
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic reviewMaryam Arabi (3927509)Yousef Al-Najjar (14147835)Omna Sharma (16449442)Ibtihal Kamal (16449445)Aimen Javed (16449448)Harsh S. Gohil (16449451)Pradipta Paul (12628162)Aljazi M. Al-Khalifa (16449454)Sa’ad Laws (9620660)Dalia Zakaria (14779459)Biomedical and clinical sciencesClinical sciencesOmicronDeltaAlphaSARS-CoV-2COVID-19EfectivenessVaccinePrevious infectionReinfection<h3>Background</h3><p dir="ltr">The SARS-CoV-2 virus elicited a major public concern worldwide since December 2019 due to the high number of infections and deaths caused by COVID-19. The Omicron variant was detected in October 2021 which evolved from the wild-type SARS-CoV-2 and was found to possess many mutations. Omicron exhibited high transmissibility and immune evasion as well as reduced severity when compared to the earlier variants. Although vaccinated individuals were largely protected against infections in previous waves, the high prevalence of both reinfections and breakthrough infections with Omicron was observed. The aim of this review is to understand the effectiveness of previous infection on subsequent reinfection, given its significance in driving public health policy, including vaccination prioritization and lockdown requirements.</p><h3>Methods</h3><p dir="ltr">A comprehensive literature search was conducted using several databases to target studies reporting data related to the effectiveness of the previous infection with SARS-CoV-2 in protecting against the Omicron variant. Screening of the studies, quality assessment and data extraction were conducted by two reviewers for each study.</p><h3>Results</h3><p dir="ltr">Only 27 studies met our inclusion criteria. It was observed that previous infection was less effective in preventing reinfections with the Omicron variant compared to the Delta variant irrespective of vaccination status. Furthermore, being fully vaccinated with a booster dose provided additional protection from the Omicron variant. Additionally, most infections caused by Omicron were asymptomatic or mild and rarely resulted in hospitalizations or death in comparison to the Delta wave.</p><h3>Conclusion</h3><p dir="ltr">A majority of the studies reached a consensus that although previous infection provides some degree of immunity against Omicron reinfection, it is much lower in comparison to Delta. Full vaccination with two doses was more protective against Delta than Omicron. Receiving a booster dose provided additional protection against Omicron. It is therefore clear that neither vaccination nor previous infection alone provide optimal protection; hybrid immunity has shown the best results in terms of protecting against either Omicron or Delta variants. However, additional research is needed to quantify how long immunity from vaccination versus previous infection lasts and whether individuals will benefit from variant-specific vaccinations to enhance protection from infection.</p><h2>Other Information</h2><p dir="ltr">Published in: BMC Infectious Diseases<br>License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1186/s12879-023-08328-3" target="_blank">https://dx.doi.org/10.1186/s12879-023-08328-3</a></p>2023-06-26T03:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1186/s12879-023-08328-3https://figshare.com/articles/journal_contribution/Role_of_previous_infection_with_SARS-CoV-2_in_protecting_against_omicron_reinfections_and_severe_complications_of_COVID-19_compared_to_pre-omicron_variants_a_systematic_review/25256638CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/252566382023-06-26T03:00:00Z
spellingShingle Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review
Maryam Arabi (3927509)
Biomedical and clinical sciences
Clinical sciences
Omicron
Delta
Alpha
SARS-CoV-2
COVID-19
Efectiveness
Vaccine
Previous infection
Reinfection
status_str publishedVersion
title Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review
title_full Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review
title_fullStr Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review
title_full_unstemmed Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review
title_short Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review
title_sort Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review
topic Biomedical and clinical sciences
Clinical sciences
Omicron
Delta
Alpha
SARS-CoV-2
COVID-19
Efectiveness
Vaccine
Previous infection
Reinfection